Podcast

Pharmacy Focus: Psychedelic Pharmacy - Potential Drug-Drug Interactions and Adverse Effects With Psychedelic Medicines

Kelan Thomas, PharmD, MS, discussed potential adverse effects and drug-drug interactions that pharmacists should be aware of with psychedelic medicines.

In the latest episode, Alana Hippensteele of Pharmacy Times sat down with Kelan Thomas, PharmD, MS, to discuss potential adverse effects and drug-drug interactions that pharmacists should be aware of with psychedelic medicines.

Related Videos
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Drug Prices, Ozempic, Biktarvy | Image Credit: lucid_dream | stock.adobe.com
January 21st 2025

Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Genetic Hemophilia Testing: Blood Sample Analysis for Inherited Condition
January 21st 2025

Proper Dosing, Bleeding Awareness Essential Roles of Pharmacists for Hemophila A and B, Thombocytopenic Purpura Treatment

Luke Halpern, Assistant Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Medical model of chronic kidney disease -- Image credit: kanruthai | stock.adobe.com
January 20th 2025

Study Shows Potential Population-Level Benefits of Intensive BP Targets in Adults With CKD

Gillian McGovern, Associate Editor
Psilocybin therapy -- Image credit: TaylerDerden | stock.adobe.com
January 17th 2025

Psilocybin May Improve Mental Health Symptoms in Patients With Cancer and Addiction

Gillian McGovern, Associate Editor